[Stage V bilateral retinoblastoma at the Curie Institute. Report of 33 cases].
Haye
C
C
Desjardins
L
L
Schlienger
P
P
Zucker
J M
JM
Laurent
M
M
D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy; D005134:Eye Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D009367:Neoplasm Staging; D012175:Retinoblastoma / Q000473:pathology / Q000628:therapy*; D012189:Retrospective Studies
D000970:Antineoplastic Agents
Rétinoblastomes bilatéraux stade V à l'Institut Curie. A propos de 33 cas.